PepJunkie Home of the Peptonauts
More

Peptide Atlas · Vitamin

Riboflavin

In a three-month randomized trial in 55 people with migraine, high-dose riboflavin (400 mg a day) reduced attack frequency and headache days more than placebo, with 59% responders against 15%.

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.